Recordati SpA (MIL:REC) Interest Expense: €-97 Mil (TTM As of Mar. 2026)


MIL:REC Recordati SpA MIL:REC
94 GF Score
Price €51.50
GF Value €60.65
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Recordati SpA Interest Expense?

Recordati SpA MIL:REC 94 Interest Expense is €-97 Mil as of Mar. 2026. GuruFocus rates MIL:REC with a GF Score™ of 94/100 and a GF Value™ of €60.65 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Recordati SpA's interest expense for the three months ended in Mar. 2026 was € -24 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was €-97 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Recordati SpA's Operating Income for the three months ended in Mar. 2026 was € 232 Mil. Recordati SpA's Interest Expense for the three months ended in Mar. 2026 was € -24 Mil. Recordati SpA's Interest Coverage for the quarter that ended in Mar. 2026 was 9.67. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Recordati SpA  (MIL:REC) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Recordati SpA's Interest Expense for the three months ended in Mar. 2026 was €-24 Mil. Its Operating Income for the three months ended in Mar. 2026 was €232 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was €1,757 Mil.

Recordati SpA's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*231.644/-23.956
=9.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Recordati SpA Interest Expense Historical Data

* Premium members only.

The historical data trend for Recordati SpA's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Recordati SpA Interest Expense Chart

Recordati SpA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.42 -32.16 -74.86 -81.55 -99.29

Recordati SpA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -26.39 -24.44 -23.23 -25.23 -23.96
MIL:REC
94GF Score
Recordati SpA MIL:REC
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Recordati SpA Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-97 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of €-97 Mil mean?
Recordati SpA (MIL:REC) has a Interest Expense of €-97 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Recordati SpA and its competitors.
Is Recordati SpA's Interest Expense too high?
Recordati SpA's current Interest Expense is €-97 Mil. Overall, Recordati SpA has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Recordati SpA's Interest Expense compare to LLY and JNJ?
Recordati SpA's Interest Expense of €-97 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Recordati SpA and its competitors. Recordati SpA's current Interest Expense is €-97 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Recordati SpA stock overvalued right now?
Based on GuruFocus' analysis, Recordati SpA (MIL:REC) is currently considered Modestly Undervalued. The stock's GF Value™ is €60.65, compared to a current price of €51.50 — trading 15.1% below its estimated fair value. The current Interest Expense is €-97 Mil. Recordati SpA's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Recordati SpA (MIL:REC), the current Interest Expense is €-97 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Recordati SpA (MIL:REC) Overvalued in 2026?

Based on GuruFocus' analysis, Recordati SpA stock appears to be undervalued. The current stock price of €51.50 is trading 15.1% below its estimated GF Value™ of €60.65. GuruFocus considers Recordati SpA to be Modestly Undervalued.

Key valuation signals for MIL:REC:

  • Interest Expense: €-97 Mil
  • GF Value™: €60.65 vs. price of €51.50 (15.1% below fair value)
  • GF Score™: 94/100 with 3 warning signs

No single metric tells the full story. See the MIL:REC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Recordati SpA Business Description

Address Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is engaged in the development, production, and marketing of pharmaceutical products or of pharmaceutical chemicals. The Company operates in a broad and diverse context, which includes general medicine, specialist medicine, self-medication, and rare diseases. In addition, it is also active in the field of urology, with treatments for benign prostatic hyperplasia and male functional disorders, and in psychiatry. The Company's only operating segment is the Specialty & Primary Care segment. Its geographic areas are Europe, Australasia, America, and Africa.
94GF Score

Get the complete analysis for MIL:REC

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€51.50
Price
€60.65
GF Value